Advisor Group Holdings, Inc. Axonics, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Axonics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,811 shares of AXNX stock, worth $128,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,811

Previous 1,793 1.0%

Holding current value

$128,544

Previous $120,000 5.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$67.3 - $69.67 $1,211 - $1,254	18 Added 1.0%	1,811 $126,000
Q2 2024 Aug 13, 2024	SELL	$66.47 - $69.65 $377,948 - $396,029	-5,686 Reduced 76.03%	1,793 $120,000
Q1 2024 May 10, 2024	SELL	$56.67 - $69.36 $125,297 - $153,354	-2,211 Reduced 22.82%	7,479 $515,000
Q4 2023 Feb 12, 2024	BUY	$49.38 - $63.75 $7,456 - $9,626	151 Added 1.58%	9,690 $603,000
Q3 2023 Nov 13, 2023	SELL	$48.64 - $62.51 $77,629 - $99,765	-1,596 Reduced 14.33%	9,539 $535,000
Q2 2023 Aug 10, 2023	BUY	$47.99 - $60.21 $78,799 - $98,864	1,642 Added 17.3%	11,135 $561,000
Q1 2023 May 12, 2023	BUY	$52.6 - $67.34 $25,931 - $33,198	493 Added 5.48%	9,493 $517,000
Q4 2022 Feb 10, 2023	SELL	$59.56 - $76.6 $677,137 - $870,865	-11,369 Reduced 55.82%	9,000 $562,000
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $750,524 - $1.01 Million	12,949 Added 174.51%	20,369 $1.44 Million
Q2 2022 Aug 10, 2022	BUY	$39.5 - $64.42 $32,232 - $52,566	816 Added 12.36%	7,420 $422,000
Q1 2022 May 04, 2022	BUY	$43.74 - $62.76 $108,737 - $156,021	2,486 Added 60.37%	6,604 $414,000
Q3 2021 Nov 05, 2021	BUY	$59.21 - $78.66 $185,623 - $246,599	3,135 Added 318.92%	4,118 $269,000
Q2 2021 Aug 02, 2021	SELL	$51.39 - $66.9 $391,797 - $510,045	-7,624 Reduced 88.58%	983 $62,000
Q1 2021 May 13, 2021	BUY	$49.14 - $59.89 $4,029 - $4,910	82 Added 0.96%	8,607 $515,000
Q4 2020 Feb 10, 2021	SELL	$42.19 - $51.5 $27,254 - $33,269	-646 Reduced 7.04%	8,525 $425,000
Q3 2020 Nov 12, 2020	BUY	$35.33 - $51.04 $3,744 - $5,410	106 Added 1.17%	9,171 $468,000
Q2 2020 Aug 14, 2020	SELL	$22.91 - $39.83 $99,085 - $172,264	-4,325 Reduced 32.3%	9,065 $318,000
Q1 2020 May 18, 2020	BUY	$16.44 - $37.73 $220,131 - $505,204	13,390 New	13,390 $340,000

Others Institutions Holding AXNX

# of Institutions

235

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Axonics, Inc. Transaction History